Literature DB >> 7681041

Antibody response and protection against challenge in mice vaccinated intraperitoneally with a live aroA O4-O9 hybrid Salmonella dublin strain.

A A Lindberg1, T Segall, A Weintraub, B A Stocker.   

Abstract

An auxotrophic Salmonella dublin (O9,12) strain, SL5631, with a deletion affecting gene aroA, was made into a partial diploid expressing the rfb (O-antigen-repeat-unit-specifying) gene cluster of Salmonella typhimurium (O4,12). By use of O4- and O9-specific antisera in indirect immunofluorescence assays, the resulting hybrid SL7103 was shown to express both the O4- and O9-antigen epitopes in the same bacterium. Qualitative and quantitative sugar analyses by gas-liquid chromatography on peralditol acetates of phenol-water-extracted lipopolysaccharides showed that the S. dublin and S. typhimurium repeating units (estimated on the basis of their tyvelose and abequose contents, respectively) were present in approximately equimolar amounts. The SL7103 hybrid auxotroph was avirulent when given intraperitoneally to NMRI mice in a dose of 10(8) CFU and elicited a protective immunity against intraperitoneal challenge with either virulent S. dublin (50% lethal dose of ca. 1.5 x 10(4) CFU versus < 1 x 10(1) CFU in nonimmunized mice) or virulent S. typhimurium (50% lethal dose of ca. 1 x 10(5) versus < 1 x 10(1) CFU in nonimmunized mice). Compared with the protection elicited in homologous systems (S. dublin SL5631 against S. dublin and S. typhimurium SL1479 against S. typhimurium), the protective efficacy of the hybrid was reduced approximately 70-fold against S. dublin challenge and 100-fold against S. typhimurium challenge. Vaccination with S. typhimurium SL1479 conferred no protection against S. dublin challenge, and vaccination with S. dublin SL5631 conferred no protection against S. typhimurium challenge. The protection elicited by the hybrid strain SL7103 is supposed to be mainly a consequence of serum antibodies directed against the immunodominant O4 and O9 epitopes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681041      PMCID: PMC281350          DOI: 10.1128/iai.61.4.1211-1221.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Characterization of aromatic- and purine-dependent Salmonella typhimurium: attention, persistence, and ability to induce protective immunity in BALB/c mice.

Authors:  D O'Callaghan; D Maskell; F Y Liew; C S Easmon; G Dougan
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

2.  Positive selection for loss of tetracycline resistance.

Authors:  B R Bochner; H C Huang; G L Schieven; B N Ames
Journal:  J Bacteriol       Date:  1980-08       Impact factor: 3.490

3.  Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors.

Authors:  D F Sigwart; B A Stocker; J D Clements
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

4.  Construction of Salmonella strains with both antigen O4 (of group B) and antigen O9 (of group D).

Authors:  B N Johnson; A Weintraub; A A Lindberg; B A Stocker
Journal:  J Bacteriol       Date:  1992-03       Impact factor: 3.490

5.  Structural and immunochemical studies of the lipopolysaccharides of Salmonella strains with both antigen O4 and antigen O9.

Authors:  A Weintraub; B N Johnson; B A Stocker; A A Lindberg
Journal:  J Bacteriol       Date:  1992-03       Impact factor: 3.490

6.  The protective capacity of immune sera in experimental mouse salmonellosis is mainly due to IgM antibodies.

Authors:  H Saxen; O Mäkelä
Journal:  Immunol Lett       Date:  1982-11       Impact factor: 3.685

7.  Immunity to Salmonella infection.

Authors:  T K Eisenstein; B M Sultzer
Journal:  Adv Exp Med Biol       Date:  1983       Impact factor: 2.622

8.  Evaluation of the immune response directed against the Salmonella antigenic factors O4,5 and O9.

Authors:  M B Lyman; B A Stocker; R J Roantree
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

9.  Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines.

Authors:  J A Robertsson; A A Lindberg; S Hoiseth; B A Stocker
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

Review 10.  Pathogenesis and immunity in murine salmonellosis.

Authors:  H S Hsu
Journal:  Microbiol Rev       Date:  1989-12
View more
  10 in total

Review 1.  Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?

Authors:  Pietro Mastroeni; Omar Rossi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

2.  Vaccination of chickens with strain CVL30, a genetically defined Salmonella enteritidis aroA live oral vaccine candidate.

Authors:  G L Cooper; L M Venables; M J Woodward; C E Hormaeche
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

3.  Phase variation of the lpf operon is a mechanism to evade cross-immunity between Salmonella serotypes.

Authors:  T L Norris; A J Bäumler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

4.  Monoclonal antibodies to lipopolysaccharide antigens of Salmonella enterica serotype Typhimurium DT104.

Authors:  Jennifer Ronholm; Zhiyi Zhang; Xundong Cao; Min Lin
Journal:  Hybridoma (Larchmt)       Date:  2011-02

5.  Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C.

Authors:  M Roberts; A Bacon; J Li; S Chatfield
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Investigation of the enzymes required for the biosynthesis of an unusual formylated sugar in the emerging human pathogen Helicobacter canadensis.

Authors:  Colton J Heisdorf; William A Griffiths; James B Thoden; Hazel M Holden
Journal:  Protein Sci       Date:  2021-08-31       Impact factor: 6.993

7.  Oral vaccination of calves with an aromatic-dependent Salmonella dublin (O9,12) hybrid expressing O4,12 protects against S. dublin (O9,12) but not against Salmonella typhimurium (O4,5,12).

Authors:  T Segall; A A Lindberg
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  Protection against salmonella typhimurium, salmonella gallinarum, and salmonella enteritidis infection in layer chickens conferred by a live attenuated salmonella typhimurium strain.

Authors:  John Hwa Lee
Journal:  Immune Netw       Date:  2015-02-17       Impact factor: 6.303

9.  Safety of the Salmonella enterica serotype Dublin strain Sdu189-derived live attenuated vaccine-A pilot study.

Authors:  Fuzhong Wang; Lei Wang; Haojie Ge; Xiaobo Wang; Yaxin Guo; Zhengzhong Xu; Shizhong Geng; Xin'an Jiao; Xiang Chen
Journal:  Front Vet Sci       Date:  2022-09-28

10.  Horizontally acquired divergent O-antigen contributes to escape from cross-immunity in the classical bordetellae.

Authors:  Sara E Hester; Jihye Park; Laura L Goodfield; Heather A Feaga; Andrew Preston; Eric T Harvill
Journal:  BMC Evol Biol       Date:  2013-09-25       Impact factor: 3.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.